Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.24 trillion and total revenue of $109.89 billion.
Market Cap
1.24T
Revenue
109.89B
Profits
-41.36B
PE Ratio
n/a
Profit Margin
-37.64%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 124.96B | 0.20% | 700,814 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 63.88B | -0.80% | 258,503 | 14.92B |
| 3 | ARGX | argenx SE | 55.63B | 1.27% | 139,559 | 4.74B |
| 4 | RVMD | Revolution Medicines, Inc. | 39.71B | 2.59% | 2,462,937 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.30B | 1.02% | 592,411 | 4.29B |
| 6 | RPRX | Royalty Pharma plc | 32.23B | -0.46% | 691,251 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 31.88B | 2.46% | 165,157 | 5.70B |
| 8 | MRNA | Moderna, Inc. | 27.26B | 2.14% | 4,238,019 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.84B | 1.38% | 2,707,724 | 8.26M |
| 10 | BNTX | BioNTech SE | 23.51B | 1.93% | 399,670 | 3.23B |
| 11 | INCY | Incyte Corporation | 22.65B | -0.34% | 506,326 | 5.36B |
| 12 | INSM | Insmed Incorporated | 22.64B | 1.02% | 1,125,469 | 819.56M |
| 13 | ASND | Ascendis Pharma A/S | 16.11B | -0.51% | 240,397 | 998.25M |
| 14 | GMAB | Genmab A/S | 15.94B | 0.17% | 1,116,537 | 3.90B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.70B | 1.84% | 209,954 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.17B | 3.02% | 1,156,432 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.72B | -0.33% | 647,569 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 13.33B | -0.62% | 882,234 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.23B | -1.65% | 394,563 | 708.24M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.88B | 0.55% | 144,763 | 1.13B |
| 21 | CYTK | Cytokinetics, Incorporated | 11.61B | 4.03% | 1,696,294 | 105.82M |
| 22 | SMMT | Summit Therapeutics Inc. | 11.22B | 3.14% | 2,484,390 | - |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.15B | 0.37% | 637,017 | 622.01M |
| 24 | TECH | Bio-Techne Corporation | 11.06B | -0.06% | 6,743,660 | 1.21B |
| 25 | KRYS | Krystal Biotech, Inc. | 11.04B | 0.59% | 118,066 | 417.30M |
| 26 | BMRN | BioMarin Pharmaceutical Inc. | 11.02B | -3.32% | 623,200 | 3.24B |
| 27 | APGE | Apogee Therapeutics, Inc. | 9.95B | 0.13% | 1,153,554 | - |
| 28 | NUVL | Nuvalent, Inc. | 9.76B | -0.01% | 776,083 | - |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 9.56B | 4.57% | 305,454 | 7.46M |
| 30 | CORT | Corcept Therapeutics Incorporated | 9.45B | 0.85% | 292,284 | 769.10M |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.12B | 2.50% | 526,155 | 51.48M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 8.99B | 1.08% | 683,846 | 1.51B |
| 33 | IBRX | ImmunityBio, Inc. | 8.88B | -2.64% | 10,598,509 | 140.98M |
| 34 | PCVX | Vaxcyte, Inc. | 8.29B | 1.54% | 880,374 | - |
| 35 | TGTX | TG Therapeutics, Inc. | 7.90B | -0.16% | 912,111 | 700.35M |
| 36 | IMVT | Immunovant, Inc. | 7.86B | -1.44% | 524,430 | - |
| 37 | SYRE | Spyre Therapeutics, Inc. | 7.81B | 2.36% | 910,729 | - |
| 38 | PTGX | Protagonist Therapeutics, Inc. | 7.68B | -1.99% | 330,158 | 74.06M |
| 39 | ABVX | ABIVAX Société Anonyme | 7.68B | -1.13% | 767,929 | 5.67M |
| 40 | MIRM | Mirum Pharmaceuticals, Inc. | 7.52B | -0.37% | 345,244 | 569.61M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.51B | -0.17% | 348,318 | 217.17M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.74B | -3.71% | 1,337,072 | 827.11M |
| 43 | SRRK | Scholar Rock Holding Corporation | 6.53B | -0.47% | 1,419,524 | - |
| 44 | COGT | Cogent Biosciences, Inc. | 6.53B | 0.24% | 1,811,344 | - |
| 45 | CGON | CG Oncology, Inc. | 6.31B | -0.57% | 440,800 | 5.07M |
| 46 | LGND | Ligand Pharmaceuticals Incorporated | 6.18B | 1.62% | 211,501 | 274.48M |
| 47 | DFTX | Definium Therapeutics, Inc. | 6.00B | 0.51% | 1,823,330 | - |
| 48 | BLTE | Belite Bio, Inc | 5.85B | 0.07% | 64,073 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.72B | -0.87% | 816,348 | 7.50M |
| 50 | ORKA | Oruka Therapeutics, Inc. | 5.67B | 3.76% | 601,453 | - |
| 51 | LEGN | Legend Biotech Corporation | 5.50B | -0.98% | 655,735 | 1.14B |
| 52 | CRSP | CRISPR Therapeutics AG | 5.48B | 3.53% | 1,181,477 | 4.10M |
| 53 | ERAS | Erasca, Inc. | 5.44B | 9.24% | 3,253,399 | - |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.40B | -1.36% | 649,989 | 536.20M |
| 55 | CAI | Caris Life Sciences, Inc. | 5.23B | - | 1,366,642 | 907.29M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 5.19B | -0.46% | 574,291 | 1.34M |
| 57 | MANE | Veradermics, Incorporated | 5.17B | -2.39% | 353,574 | - |
| 58 | CELC | Celcuity Inc. | 4.91B | 0.74% | 450,290 | - |
| 59 | TNGX | Tango Therapeutics, Inc. | 4.57B | 0.38% | 2,600,298 | 56.99M |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.44B | 0.47% | 1,307,954 | - |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 4.33B | -2.99% | 762,512 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.29B | 6.09% | 1,520,980 | 10.68M |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 4.29B | -1.05% | 931,991 | 1.10B |
| 64 | DNLI | Denali Therapeutics Inc. | 4.06B | 0.12% | 678,679 | - |
| 65 | RCUS | Arcus Biosciences, Inc. | 3.90B | -0.03% | 387,246 | 236.00M |
| 66 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.86B | -0.27% | 356,815 | 18.07M |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.85B | -0.84% | 466,665 | 22.57M |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | -0.17% | 610,104 | 596.96M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.79B | 6.19% | 151,031 | 803.79M |
| 70 | PBLS | Parabilis Medicines, Inc. | 3.67B | 0.17% | 314,273 | - |
| 71 | GPCR | Structure Therapeutics Inc. | 3.59B | 1.67% | 224,763 | - |
| 72 | BEAM | Beam Therapeutics Inc. | 3.54B | 2.21% | 1,593,991 | 164.01M |
| 73 | ELVN | Enliven Therapeutics, Inc. | 3.50B | 0.08% | 438,088 | - |
| 74 | DYN | Dyne Therapeutics, Inc. | 3.48B | 0.57% | 1,001,399 | - |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.48B | -0.52% | 352,287 | 225.27M |
| 76 | ALMS | Alumis Inc. | 3.43B | 1.86% | 711,542 | 8.40M |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 3.36B | -0.54% | 556,561 | 415.62M |
| 78 | QURE | uniQure N.V. | 3.27B | 0.11% | 1,278,848 | 18.09M |
| 79 | VERA | Vera Therapeutics, Inc. | 3.12B | 2.52% | 1,762,733 | - |
| 80 | RARE | Ultragenyx Pharmaceutical Inc. | 3.00B | -0.65% | 920,850 | 670.00M |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.84B | 2.52% | 623,869 | 865.00K |
| 82 | KLRA | Kailera Therapeutics, Inc. | 2.78B | 2.93% | 248,205 | - |
| 83 | IRON | Disc Medicine, Inc. | 2.75B | -3.77% | 368,040 | - |
| 84 | TARS | Tarsus Pharmaceuticals, Inc. | 2.67B | -1.27% | 330,783 | 535.08M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.64B | 14.69% | 21,033,481 | - |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.59B | 0.66% | 1,371,712 | - |
| 87 | MBX | MBX Biosciences, Inc. | 2.57B | 3.08% | 453,179 | - |
| 88 | ABCL | AbCellera Biologics Inc. | 2.50B | 10.91% | 10,882,405 | 79.21M |
| 89 | NRIX | Nurix Therapeutics, Inc. | 2.46B | 3.71% | 1,063,716 | 71.78M |
| 90 | PHVS | Pharvaris N.V. | 2.41B | 1.47% | 240,067 | - |
| 91 | VCEL | Vericel Corporation | 2.33B | -1.10% | 241,952 | 292.09M |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.32B | -1.56% | 653,035 | - |
| 93 | KOD | Kodiak Sciences Inc. | 2.31B | 2.95% | 346,034 | - |
| 94 | KARD | Kardigan, Inc. | 2.30B | 9.03% | 564,011 | - |
| 95 | NTLA | Intellia Therapeutics, Inc. | 2.30B | -1.50% | 2,970,044 | 66.09M |
| 96 | IMNM | Immunome, Inc. | 2.25B | -0.48% | 419,800 | 4.02M |
| 97 | BHVN | Biohaven Ltd. | 2.25B | -5.62% | 1,651,153 | - |
| 98 | AGIO | Agios Pharmaceuticals, Inc. | 2.25B | -0.29% | 251,751 | 66.05M |
| 99 | NKTR | Nektar Therapeutics | 2.21B | 2.70% | 311,154 | 55.63M |
| 100 | GENB | Generate Biomedicines, Inc. | 2.20B | 4.25% | 1,051,511 | 30.30M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -3.25% | 1,584,083 | 298.30M |
| 102 | OCUL | Ocular Therapeutix, Inc. | 2.14B | -0.71% | 873,508 | 52.04M |
| 103 | TSHA | Taysha Gene Therapies, Inc. | 2.13B | 5.05% | 2,224,877 | 7.47M |
| 104 | PGEN | Precigen, Inc. | 2.11B | 1.02% | 3,217,682 | 31.60M |
| 105 | PVLA | Palvella Therapeutics, Inc. | 2.09B | -1.84% | 182,361 | - |
| 106 | VRDN | Viridian Therapeutics, Inc. | 2.07B | 4.86% | 4,410,864 | 70.92M |
| 107 | ZLAB | Zai Lab Limited | 2.04B | 0.78% | 389,550 | 453.28M |
| 108 | HRMY | Harmony Biosciences Holdings, Inc. | 2.03B | -1.04% | 306,275 | 899.11M |
| 109 | STOK | Stoke Therapeutics, Inc. | 1.99B | -0.28% | 278,764 | 32.08M |
| 110 | RXRX | Recursion Pharmaceuticals, Inc. | 1.97B | 5.54% | 16,557,070 | 66.41M |
| 111 | ADMA | ADMA Biologics, Inc. | 1.95B | -3.66% | 1,206,496 | 509.86M |
| 112 | SNDX | Syndax Pharmaceuticals, Inc. | 1.94B | 2.91% | 2,696,570 | 217.17M |
| 113 | GLUE | Monte Rosa Therapeutics, Inc. | 1.94B | 3.19% | 464,451 | 42.95M |
| 114 | GHRS | GH Research PLC | 1.94B | 0.11% | 120,595 | - |
| 115 | RAPP | Rapport Therapeutics, Inc. | 1.94B | 1.04% | 172,938 | 20.00M |
| 116 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 0.03% | 58,152 | 1.20B |
| 117 | ATAI | AtaiBeckley Inc. | 1.93B | -0.85% | 5,607,664 | 3.49M |
| 118 | SION | Sionna Therapeutics, Inc. | 1.93B | 1.38% | 133,700 | - |
| 119 | NUVB | Nuvation Bio Inc. | 1.93B | -1.95% | 4,927,370 | 143.05M |
| 120 | IOVA | Iovance Biotherapeutics, Inc. | 1.90B | 0.24% | 5,266,817 | 285.61M |
| 121 | ABSI | Absci Corporation | 1.89B | 2.48% | 5,645,903 | 1.84M |
| 122 | TYRA | Tyra Biosciences, Inc. | 1.87B | -1.25% | 238,159 | - |
| 123 | ANAB | AnaptysBio, Inc. | 1.86B | 0.98% | 242,344 | 232.39M |
| 124 | BCAX | Bicara Therapeutics Inc. | 1.85B | 4.84% | 535,225 | - |
| 125 | NBTX | Nanobiotix S.A. | 1.80B | -1.19% | 62,099 | 38.27M |
| 126 | SRPT | Sarepta Therapeutics, Inc. | 1.80B | 1.01% | 1,465,193 | 2.18B |
| 127 | COAG | Hemab Therapeutics Holdings, Inc. | 1.77B | 16.93% | 177,166 | - |
| 128 | MESO | Mesoblast Limited | 1.74B | 2.85% | 90,342 | 65.38M |
| 129 | VIR | Vir Biotechnology, Inc. | 1.74B | 3.09% | 713,895 | 65.50M |
| 130 | ZYME | Zymeworks Inc. | 1.73B | -1.90% | 627,693 | 81.26M |
| 131 | INVA | Innoviva, Inc. | 1.72B | -0.93% | 338,848 | 420.69M |
| 132 | AKTS | Aktis Oncology, Inc. | 1.71B | 5.26% | 226,128 | 8.28M |
| 133 | URGN | UroGen Pharma Ltd. | 1.71B | 1.77% | 225,311 | 140.49M |
| 134 | MLTX | MoonLake Immunotherapeutics | 1.66B | 0.90% | 647,404 | - |
| 135 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.65B | 2.65% | 1,599,841 | 204.73M |
| 136 | FTRE | Fortrea Holdings Inc. | 1.64B | -1.59% | 576,274 | 2.71B |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.60B | 1.86% | 294,534 | 20.00M |
| 138 | ZBIO | Zenas BioPharma, Inc. | 1.59B | -2.86% | 753,515 | 10.00M |
| 139 | AVBP | ArriVent BioPharma, Inc. | 1.59B | 0.15% | 196,385 | - |
| 140 | AAPG | Ascentage Pharma Group International | 1.58B | 6.08% | 7,731 | 82.08M |
| 141 | IMCR | Immunocore Holdings plc | 1.56B | -0.84% | 275,808 | 412.81M |
| 142 | SEPN | Septerna, Inc. | 1.54B | -8.57% | 759,294 | 72.26M |
| 143 | MPLT | MapLight Therapeutics, Inc. | 1.53B | 1.26% | 157,135 | - |
| 144 | SVRA | Savara Inc. | 1.52B | 1.36% | 553,973 | - |
| 145 | NVAX | Novavax, Inc. | 1.50B | 2.82% | 2,285,772 | 596.34M |
| 146 | DMRA | Damora Therapeutics, Inc. | 1.48B | -4.89% | 222,532 | - |
| 147 | CAPR | Capricor Therapeutics, Inc. | 1.38B | -9.80% | 2,176,287 | 11.13M |
| 148 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -1.39% | 227,262 | 1.30M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.36B | -0.36% | 115,121 | - |
| 150 | JBIO | Jade Biosciences, Inc. | 1.35B | 3.16% | 401,706 | - |
| 151 | ARDX | Ardelyx, Inc. | 1.33B | -3.15% | 5,414,563 | 427.68M |
| 152 | MNKD | MannKind Corporation | 1.31B | 2.17% | 1,628,478 | 360.78M |
| 153 | IMTX | Immatics N.V. | 1.30B | -0.37% | 90,790 | 43.00M |
| 154 | SPTX | Seaport Therapeutics, Inc. | 1.19B | 3.62% | 46,725 | - |
| 155 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | 4.00% | 830,248 | - |
| 156 | EYPT | EyePoint, Inc. | 1.18B | 2.86% | 561,770 | 7.61M |
| 157 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.17B | 2.94% | 2,275,815 | 69.64M |
| 158 | MGTX | MeiraGTx Holdings plc | 1.14B | 1.57% | 253,187 | 79.76M |
| 159 | CGEM | Cullinan Therapeutics, Inc. | 1.13B | -0.16% | 300,900 | - |
| 160 | XNCR | Xencor, Inc. | 1.11B | -0.40% | 273,779 | 97.36M |
| 161 | WVE | Wave Life Sciences Ltd. | 1.09B | -2.57% | 1,113,797 | 71.80M |
| 162 | OLMA | Olema Pharmaceuticals, Inc. | 1.05B | 5.79% | 665,752 | - |
| 163 | SANA | Sana Biotechnology, Inc. | 1.03B | 0.88% | 1,265,255 | - |
| 164 | ORIC | ORIC Pharmaceuticals, Inc. | 1.03B | 4.30% | 351,308 | - |
| 165 | DRTS | Alpha Tau Medical Ltd. | 1.03B | 4.78% | 518,935 | - |
| 166 | AVTX | Avalo Therapeutics, Inc. | 1.02B | 6.35% | 945,353 | 59.00K |
| 167 | VOR | Vor Biopharma Inc. | 988.35M | 13.29% | 1,790,567 | - |
| 168 | KURA | Kura Oncology, Inc. | 972.08M | 0.46% | 494,061 | 71.64M |
| 169 | DBVT | DBV Technologies S.A. | 969.96M | -0.06% | 266,693 | 5.74M |
| 170 | ANRO | Alto Neuroscience, Inc. | 947.54M | -0.15% | 226,803 | - |
| 171 | PHAR | Pharming Group N.V. | 939.20M | -0.52% | 4,271 | 369.49M |
| 172 | REPL | Replimune Group, Inc. | 929.35M | -3.22% | 1,864,788 | - |
| 173 | SLDB | Solid Biosciences Inc. | 920.50M | 0.65% | 570,710 | - |
| 174 | JANX | Janux Therapeutics, Inc. | 917.81M | 0.74% | 456,325 | 13.73M |
| 175 | LBRX | LB Pharmaceuticals Inc | 916.51M | 0.13% | 213,096 | - |
| 176 | ABUS | Arbutus Biopharma Corporation | 912.62M | 0.87% | 726,767 | 191.45M |
| 177 | ANNX | Annexon, Inc. | 909.33M | 1.28% | 1,063,940 | - |
| 178 | TBPH | Theravance Biopharma, Inc. | 888.77M | -2.21% | 2,266,447 | 109.78M |
| 179 | ODTX | Odyssey Therapeutics, Inc. | 885.26M | 2.38% | 109,653 | 1.06M |
| 180 | GERN | Geron Corporation | 869.26M | 2.65% | 7,513,141 | 196.12M |
| 181 | DSGN | Design Therapeutics, Inc. | 863.16M | 3.52% | 570,342 | - |
| 182 | PHAT | Phathom Pharmaceuticals, Inc. | 849.90M | -0.19% | 432,954 | 204.89M |
| 183 | SPRY | ARS Pharmaceuticals, Inc. | 831.17M | -1.99% | 513,934 | 98.99M |
| 184 | ZVRA | Zevra Therapeutics, Inc. | 831.16M | 3.99% | 826,730 | 122.29M |
| 185 | CTMX | CytomX Therapeutics, Inc. | 798.97M | 7.94% | 2,587,376 | 35.54M |
| 186 | IVA | Inventiva S.A. | 772.09M | 2.20% | 460,721 | 7.94M |
| 187 | ALLO | Allogene Therapeutics, Inc. | 762.79M | 3.76% | 7,546,932 | 22.00K |
| 188 | AURA | Aura Biosciences, Inc. | 762.72M | -1.21% | 163,852 | - |
| 189 | CLYM | Climb Bio, Inc. | 761.56M | 1.68% | 481,924 | - |
| 190 | CADL | Candel Therapeutics, Inc. | 754.68M | 5.21% | 890,479 | - |
| 191 | OCS | Oculis Holding AG | 751.83M | 3.75% | 344,978 | 1.40M |
| 192 | AGMB | AgomAb Therapeutics NV | 738.23M | 8.54% | 49,571 | - |
| 193 | NVCT | Nuvectis Pharma, Inc. | 726.00M | 0.66% | 209,145 | - |
| 194 | IMMX | Immix Biopharma, Inc. | 717.59M | 1.00% | 691,779 | - |
| 195 | SGP | SpyGlass Pharma, Inc. | 712.46M | 0.61% | 46,349 | - |
| 196 | RLMD | Relmada Therapeutics, Inc. | 710.11M | 1.20% | 890,805 | - |
| 197 | RIGL | Rigel Pharmaceuticals, Inc. | 709.00M | -0.96% | 113,722 | 299.77M |
| 198 | ACRS | Aclaris Therapeutics, Inc. | 702.51M | 0.60% | 572,164 | 8.37M |
| 199 | DNA | Ginkgo Bioworks Holdings, Inc. | 685.25M | 2.34% | 879,045 | 151.40M |
| 200 | FDMT | 4D Molecular Therapeutics, Inc. | 682.21M | 12.50% | 768,046 | 88.24M |
| 201 | OMER | Omeros Corporation | 681.05M | 8.54% | 1,474,715 | 9.89M |
| 202 | EIKN | Eikon Therapeutics, Inc. | 676.73M | 9.17% | 207,539 | - |
| 203 | TENX | Tenax Therapeutics, Inc. | 676.20M | -1.53% | 273,861 | - |
| 204 | PRME | Prime Medicine, Inc. | 668.28M | 7.87% | 3,480,513 | 4.03M |
| 205 | MNPR | Monopar Therapeutics Inc. | 630.56M | 7.36% | 64,969 | - |
| 206 | ACHV | Achieve Life Sciences, Inc. | 629.81M | 1.91% | 1,220,757 | - |
| 207 | CBIO | Crescent Biopharma, Inc. | 627.03M | 1.67% | 150,840 | 11.88M |
| 208 | DRUG | Bright Minds Biosciences Inc. | 619.56M | 2.90% | 158,550 | - |
| 209 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 606.81M | 2.36% | 116,358 | - |
| 210 | TECX | Tectonic Therapeutic, Inc. | 606.64M | 0.50% | 81,791 | - |
| 211 | FTH | Faeth Therapeutics, Inc. | 600.90M | 1.92% | 52,788 | - |
| 212 | CRMD | CorMedix Inc. | 594.67M | -3.44% | 687,395 | 400.05M |
| 213 | PROK | ProKidney Corp. | 586.00M | 6.01% | 698,505 | 889.00K |
| 214 | MDXG | MiMedx Group, Inc. | 578.65M | -1.15% | 560,412 | 389.42M |
| 215 | TRAX | First Tracks Biotherapeutics, Inc. | 576.07M | 2.99% | 108,499 | - |
| 216 | RGNX | REGENXBIO Inc. | 573.84M | 5.92% | 1,148,741 | 87.82M |
| 217 | GYRE | Gyre Therapeutics, Inc. | 573.82M | -0.16% | 47,598 | 117.05M |
| 218 | OCGN | Ocugen, Inc. | 567.02M | 11.67% | 8,287,730 | 4.47M |
| 219 | EVMN | Evommune, Inc. | 563.69M | -37.85% | 5,604,975 | 10.00M |
| 220 | CTNM | Contineum Therapeutics, Inc. | 554.07M | 4.44% | 186,637 | - |
| 221 | ALT | Altimmune, Inc. | 551.33M | 0.53% | 1,460,982 | 36.00K |
| 222 | FBRX | Forte Biosciences, Inc. | 544.43M | 5.94% | 154,398 | - |
| 223 | ARVN | Arvinas, Inc. | 543.27M | 5.25% | 322,909 | 89.40M |
| 224 | STRO | Sutro Biopharma, Inc. | 540.36M | 6.85% | 172,498 | 99.61M |
| 225 | RZLT | Rezolute, Inc. | 536.95M | 1.98% | 713,131 | - |
| 226 | SLBT | SL Science Holding Limited | 530.13M | -12.53% | 165,774 | - |
| 227 | ZURA | Zura Bio Limited | 530.09M | 4.30% | 1,348,065 | - |
| 228 | KYTX | Kyverna Therapeutics, Inc. | 528.31M | 2.96% | 707,986 | - |
| 229 | XOMA | XOMA Royalty Corporation | 527.60M | -0.19% | 256,092 | 48.56M |
| 230 | ASMB | Assembly Biosciences, Inc. | 518.22M | -2.21% | 122,097 | 71.10M |
| 231 | PRTA | Prothena Corporation plc | 516.73M | -1.50% | 159,796 | 57.94M |
| 232 | CABA | Cabaletta Bio, Inc. | 508.73M | 2.63% | 3,099,041 | - |
| 233 | NGNE | Neurogene Inc. | 505.11M | -0.20% | 148,490 | 925.00K |
| 234 | SLN | Silence Therapeutics plc | 497.37M | 3.85% | 446,539 | 839.00K |
| 235 | STTK | Shattuck Labs, Inc. | 493.06M | -0.16% | 1,080,066 | 1.00M |
| 236 | EDIT | Editas Medicine, Inc. | 488.01M | 11.58% | 1,953,623 | 38.69M |
| 237 | CCCC | C4 Therapeutics, Inc. | 486.50M | 3.29% | 1,728,179 | 34.86M |
| 238 | VALN | Valneva SE | 482.77M | 0.96% | 29,998 | 180.25M |
| 239 | OVID | Ovid Therapeutics Inc. | 481.53M | 1.18% | 613,676 | 7.12M |
| 240 | ARTV | Artiva Biotherapeutics, Inc. | 472.52M | 1.09% | 173,733 | 251.00K |
| 241 | PRLD | Prelude Therapeutics Incorporated | 468.12M | 7.76% | 242,593 | 16.72M |
| 242 | VTVT | vTv Therapeutics Inc. | 442.40M | 1.62% | 47,456 | 36.84M |
| 243 | SGMT | Sagimet Biosciences Inc. | 434.73M | -0.28% | 370,194 | - |
| 244 | AUTL | Autolus Therapeutics plc | 432.48M | 0.93% | 478,702 | 92.62M |
| 245 | EPRX | Eupraxia Pharmaceuticals Inc. | 431.88M | -0.15% | 257,152 | - |
| 246 | BNTC | Benitec Biopharma Inc. | 424.62M | -0.08% | 35,079 | - |
| 247 | IPSC | Century Therapeutics, Inc. | 414.82M | -0.86% | 925,891 | 109.16M |
| 248 | HELP | Cybin Inc. | 414.67M | 3.24% | 1,060,667 | - |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 412.91M | 1.43% | 117,006 | 69.21M |
| 250 | PBYI | Puma Biotechnology, Inc. | 411.27M | -0.37% | 140,372 | 227.18M |
| 251 | ANL | Adlai Nortye Ltd. | 409.80M | 2.45% | 16,055 | 5.00M |
| 252 | XFOR | X4 Pharmaceuticals, Inc. | 392.37M | 3.48% | 252,966 | 9.01M |
| 253 | CMPX | Compass Therapeutics, Inc. | 388.09M | 3.61% | 912,280 | 850.00K |
| 254 | FENC | Fennec Pharmaceuticals Inc. | 385.23M | 0.64% | 101,953 | 51.00M |
| 255 | PALI | Palisade Bio, Inc. | 380.14M | 15.87% | 6,049,619 | - |
| 256 | DMAC | DiaMedica Therapeutics Inc. | 373.41M | 5.80% | 203,653 | - |
| 257 | OABI | OmniAb, Inc. | 371.85M | 1.79% | 167,597 | 28.94M |
| 258 | LXEO | Lexeo Therapeutics, Inc. | 371.01M | -0.53% | 318,844 | - |
| 259 | UPB | Upstream Bio, Inc. | 366.25M | -0.30% | 183,608 | 3.32M |
| 260 | RCKT | Rocket Pharmaceuticals, Inc. | 365.80M | 3.08% | 827,226 | - |
| 261 | AVIR | Atea Pharmaceuticals, Inc. | 364.12M | 1.34% | 163,691 | - |
| 262 | VNDA | Vanda Pharmaceuticals Inc. | 362.92M | 0.42% | 381,934 | 217.78M |
| 263 | INDP | Indaptus Therapeutics, Inc. | 352.18M | -8.80% | 108,959 | - |
| 264 | VSTM | Verastem, Inc. | 334.80M | 0.79% | 1,397,120 | 49.59M |
| 265 | LCTX | Lineage Cell Therapeutics, Inc. | 331.57M | 3.91% | 811,918 | 14.78M |
| 266 | IRD | Opus Genetics, Inc. | 331.28M | 1.75% | 370,766 | 11.98M |
| 267 | GLSI | Greenwich LifeSciences, Inc. | 330.11M | 13.59% | 123,754 | - |
| 268 | IKT | Inhibikase Therapeutics, Inc. | 327.21M | 0.52% | 278,076 | 1.00 |
| 269 | IMRX | Immuneering Corporation | 326.72M | 6.09% | 1,138,152 | - |
| 270 | GALT | Galectin Therapeutics Inc. | 326.65M | -0.60% | 1,103,087 | - |
| 271 | IFRX | InflaRx N.V. | 326.25M | 15.36% | 2,048,129 | 33.82K |
| 272 | ABEO | Abeona Therapeutics Inc. | 322.59M | 0.89% | 564,791 | 14.54M |
| 273 | ZNTL | Zentalis Pharmaceuticals, Inc. | 322.47M | 12.13% | 2,077,787 | 26.87M |
| 274 | LRMR | Larimar Therapeutics, Inc. | 321.50M | -15.85% | 10,408,141 | - |
| 275 | MGNX | MacroGenics, Inc. | 310.19M | 1.46% | 488,003 | 157.08M |
| 276 | NMRA | Neumora Therapeutics, Inc. | 303.87M | - | 704,666 | - |
| 277 | SABS | SAB Biotherapeutics, Inc. | 303.56M | 4.47% | 275,463 | 114.70K |
| 278 | SRZN | Surrozen, Inc. | 302.28M | 3.23% | 47,267 | 7.49M |
| 279 | ELDN | Eledon Pharmaceuticals, Inc. | 296.07M | 1.32% | 1,181,702 | - |
| 280 | ALXO | ALX Oncology Holdings Inc. | 294.69M | 7.35% | 1,415,073 | - |
| 281 | LYEL | Lyell Immunopharma, Inc. | 291.91M | 7.75% | 87,172 | 31.00K |
| 282 | BCYC | Bicycle Therapeutics plc | 291.46M | 1.83% | 215,064 | 63.50M |
| 283 | CNXU | Conexeu Sciences Inc. | 278.96M | -4.88% | 23,368 | - |
| 284 | IVVD | Invivyd, Inc. | 276.49M | 5.25% | 1,555,879 | 55.87M |
| 285 | FATE | Fate Therapeutics, Inc. | 275.66M | 12.62% | 3,793,670 | 6.32M |
| 286 | ADAG | Adagene Inc. | 275.52M | -0.48% | 56,649 | 7.67M |
| 287 | RNAC | Cartesian Therapeutics, Inc. | 275.16M | -0.58% | 75,450 | 1.78M |
| 288 | FHTX | Foghorn Therapeutics Inc. | 274.78M | 10.90% | 250,271 | 28.22M |
| 289 | TRDA | Entrada Therapeutics, Inc. | 271.69M | -2.58% | 94,762 | 5.74M |
| 290 | OBIO | Orchestra BioMed Holdings, Inc. | 266.47M | 4.95% | 271,722 | 32.72M |
| 291 | NAGE | Niagen Bioscience, Inc. | 263.38M | -3.51% | 391,309 | 130.42M |
| 292 | ACIU | AC Immune SA | 255.94M | 0.78% | 76,310 | 4.62M |
| 293 | QTTB | Q32 Bio Inc. | 250.11M | 12.00% | 414,693 | 53.74M |
| 294 | FULC | Fulcrum Therapeutics, Inc. | 247.88M | -2.11% | 762,241 | 80.00M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 242.69M | 1.01% | 8,506 | 18.47M |
| 296 | NBP | NovaBridge Biosciences | 239.97M | 26.52% | 2,776,813 | - |
| 297 | AVXL | Anavex Life Sciences Corp. | 235.85M | -2.86% | 431,387 | - |
| 298 | NERV | Minerva Neurosciences, Inc. | 234.22M | 15.05% | 118,156 | - |
| 299 | ARMP | Armata Pharmaceuticals, Inc. | 231.28M | -14.86% | 130,493 | 5.20M |
| 300 | TARA | Protara Therapeutics, Inc. | 230.44M | -0.49% | 446,606 | - |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 229.65M | 2.64% | 112,243 | 7.15M |
| 302 | RNA | Atrium Therapeutics, Inc. | 229.22M | 1.59% | 103,715 | 36.68M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 226.92M | 4.05% | 95,083 | 3.93M |
| 304 | CHRS | Coherus Oncology, Inc. | 226.75M | -2.00% | 654,150 | 46.88M |
| 305 | NAUT | Nautilus Biotechnology, Inc. | 225.56M | -11.25% | 1,250,081 | - |
| 306 | KPTI | Karyopharm Therapeutics Inc. | 222.78M | -3.72% | 212,192 | 151.12M |
| 307 | HUMA | Humacyte, Inc. | 216.38M | 13.25% | 23,144,888 | 2.02M |
| 308 | CDXS | Codexis, Inc. | 215.88M | -0.63% | 387,258 | 78.09M |
| 309 | VYGR | Voyager Therapeutics, Inc. | 215.40M | -0.70% | 370,824 | 36.49M |
| 310 | KROS | Keros Therapeutics, Inc. | 213.75M | -1.73% | 205,869 | 33.18M |
| 311 | ALEC | Alector, Inc. | 213.17M | 3.23% | 226,034 | 18.42M |
| 312 | UNCY | Unicycive Therapeutics, Inc. | 210.13M | 10.38% | 1,522,618 | - |
| 313 | IMUX | Immunic, Inc. | 208.15M | -0.12% | 160,578 | - |
| 314 | OTLK | Outlook Therapeutics, Inc. | 206.68M | - | 4,786,914 | 333.14K |
| 315 | NGEN | NervGen Pharma Corp. | 206.03M | 3.74% | 395,149 | - |
| 316 | NKTX | Nkarta, Inc. | 203.90M | 0.71% | 310,668 | - |
| 317 | TNXP | Tonix Pharmaceuticals Holding Corp. | 203.40M | -3.48% | 316,605 | 17.56M |
| 318 | CLLS | Cellectis S.A. | 202.87M | 1.77% | 8,022 | 75.11M |
| 319 | CGEN | Compugen Ltd. | 202.41M | 2.39% | 140,277 | 72.66M |
| 320 | TTRX | Turn Therapeutics Inc. | 201.52M | -2.38% | 6,339 | - |
| 321 | DTIL | Precision BioSciences, Inc. | 197.90M | 5.21% | 355,404 | 45.07M |
| 322 | MDWD | MediWound Ltd. | 195.10M | -0.07% | 22,358 | 14.48M |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 194.65M | 14.19% | 479,788 | - |
| 324 | ARCT | Arcturus Therapeutics Holdings Inc. | 192.71M | -1.45% | 209,225 | 54.71M |
| 325 | EQ | Equillium, Inc. | 192.52M | -0.16% | 167,830 | 4.39M |
| 326 | CNTN | Canton Strategic Holdings, Inc. | 191.61M | -7.58% | 393,670 | - |
| 327 | PLX | Protalix BioTherapeutics, Inc. | 190.95M | 3.04% | 245,495 | 76.38M |
| 328 | PRQR | ProQR Therapeutics N.V. | 190.71M | 18.30% | 1,683,717 | 15.73M |
| 329 | OKUR | OnKure Therapeutics, Inc. | 184.61M | 1.56% | 214,628 | - |
| 330 | KRRO | Korro Bio, Inc. | 184.04M | 0.47% | 77,048 | 3.84M |
| 331 | ORMP | Oramed Pharmaceuticals Inc. | 182.53M | -4.50% | 198,399 | 2.00M |
| 332 | PYXS | Pyxis Oncology, Inc. | 179.61M | 2.35% | 582,449 | 13.86M |
| 333 | ANTX | AN2 Therapeutics, Inc. | 178.64M | -4.62% | 139,706 | - |
| 334 | LENZ | LENZ Therapeutics, Inc. | 177.31M | -2.84% | 251,694 | 20.99M |
| 335 | CRBU | Caribou Biosciences, Inc. | 176.54M | 5.95% | 1,771,799 | 11.20M |
| 336 | YDES | YD Bio Limited | 175.80M | 6.38% | 8,715 | 510.36K |
| 337 | MIST | Milestone Pharmaceuticals Inc. | 175.50M | 4.03% | 714,953 | 1.78M |
| 338 | NRXP | NRx Pharmaceuticals, Inc. | 168.90M | 8.04% | 716,489 | 2.29M |
| 339 | IPHA | Innate Pharma S.A. | 168.65M | 4.19% | 30,478 | 10.57M |
| 340 | KZIA | Kazia Therapeutics Limited | 168.38M | 3.62% | 113,311 | 1.27M |
| 341 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 162.30M | 0.23% | 186,021 | - |
| 342 | TNYA | Tenaya Therapeutics, Inc. | 161.95M | 4.01% | 1,207,767 | 225.00K |
| 343 | TLSA | Tiziana Life Sciences Ltd | 160.34M | 5.08% | 126,274 | - |
| 344 | MENS | Jyong Biotech Ltd. | 159.60M | 14.36% | 112,827 | - |
| 345 | SPRB | Spruce Biosciences, Inc. | 153.11M | 0.94% | 36,756 | 697.00K |
| 346 | ACOG | Alpha Cognition Inc. | 148.72M | 5.08% | 13,109 | 10.83M |
| 347 | MOLN | Molecular Partners AG | 147.59M | 1.05% | 7,016 | 856.30K |
| 348 | HURA | TuHURA Biosciences, Inc. | 145.20M | 5.56% | 516,846 | - |
| 349 | CNTB | Connect Biopharma Holdings Limited | 142.30M | 3.20% | 142,329 | 233.00K |
| 350 | ENLV | Enlivex Ltd. | 136.46M | -0.68% | 129,568 | - |
| 351 | COYA | Coya Therapeutics, Inc. | 134.29M | 4.09% | 124,638 | 7.94M |
| 352 | AGEN | Agenus Inc. | 132.42M | 4.95% | 579,696 | 123.87M |
| 353 | SPRO | Spero Therapeutics, Inc. | 131.73M | 0.66% | 293,941 | 61.19M |
| 354 | ADCT | ADC Therapeutics SA | 131.64M | 1.47% | 448,613 | 79.18M |
| 355 | GNLX | Genelux Corporation | 128.56M | 0.87% | 132,669 | 8.00K |
| 356 | GUTS | Fractyl Health, Inc. | 124.90M | 5.96% | 302,983 | 3.00K |
| 357 | PEPG | PepGen Inc. | 122.08M | 3.82% | 147,944 | - |
| 358 | ENGN | enGene Therapeutics Inc. | 118.91M | 1.43% | 698,603 | - |
| 359 | ALDX | Aldeyra Therapeutics, Inc. | 118.83M | 7.65% | 918,609 | - |
| 360 | PLYX | Polaryx Therapeutics, Inc. | 117.41M | 3.33% | 296,578 | - |
| 361 | CUE | Cue Biopharma, Inc. | 117.33M | 14.22% | 105,975 | 32.73M |
| 362 | ONCY | Oncolytics Biotech Inc. | 114.58M | 1.29% | 629,098 | - |
| 363 | NTHI | NeOnc Technologies Holdings, Inc. | 114.56M | -1.20% | 31,801 | 39.99K |
| 364 | AARD | Aardvark Therapeutics, Inc. | 109.63M | 4.91% | 83,841 | - |
| 365 | VRCA | Verrica Pharmaceuticals Inc. | 109.09M | -7.16% | 23,885 | 37.16M |
| 366 | CBUS | Cibus, Inc. | 105.34M | 1.47% | 150,065 | 4.29M |
| 367 | KLRS | Kalaris Therapeutics, Inc. | 103.73M | 0.93% | 26,996 | - |
| 368 | VANI | Vivani Medical, Inc. | 103.05M | -0.42% | 33,731 | - |
| 369 | BMEA | Biomea Fusion, Inc. | 100.50M | 5.30% | 526,390 | - |
| 370 | ALPS | Alps Group Inc | 99.84M | -0.99% | 55,253 | 3.74M |
| 371 | BDTX | Black Diamond Therapeutics, Inc. | 99.13M | 1.17% | 713,022 | 70.00M |
| 372 | PMN | ProMIS Neurosciences, Inc. | 98.64M | 4.46% | 13,154 | - |
| 373 | ATRA | Atara Biotherapeutics, Inc. | 98.30M | 3.81% | 28,130 | 23.14M |
| 374 | PTHS | Pelthos Therapeutics Inc. | 97.96M | -2.91% | 22,630 | 27.70M |
| 375 | LIXT | Lixte Biotechnology Holdings, Inc. | 96.22M | 8.07% | 249,744 | - |
| 376 | CGTX | Cognition Therapeutics, Inc. | 95.76M | -4.46% | 1,277,879 | - |
| 377 | FBIO | Fortress Biotech, Inc. | 95.50M | 4.17% | 414,069 | 66.16M |
| 378 | PYPD | PolyPid Ltd. | 95.49M | 4.84% | 286,194 | - |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 93.66M | 2.73% | 359,724 | 3.17M |
| 380 | SEER | Seer, Inc. | 93.47M | 2.41% | 35,230 | 15.17M |
| 381 | INO | Inovio Pharmaceuticals, Inc. | 92.15M | 1.82% | 726,342 | 65.34K |
| 382 | RNTX | Rein Therapeutics Inc. | 92.11M | 1.94% | 567,115 | - |
| 383 | OSTX | OS Therapies Incorporated | 91.75M | 9.57% | 852,981 | - |
| 384 | ANIX | Anixa Biosciences, Inc. | 91.18M | -3.94% | 306,698 | - |
| 385 | ACET | Adicet Bio, Inc. | 89.47M | 1.79% | 45,807 | - |
| 386 | ICCC | ImmuCell Corporation | 89.11M | 0.61% | 16,005 | 29.93M |
| 387 | MAIA | MAIA Biotechnology, Inc. | 89.07M | 3.90% | 445,017 | - |
| 388 | NRXS | NeurAxis, Inc. | 88.80M | -1.38% | 30,810 | 4.28M |
| 389 | CRDF | Cardiff Oncology, Inc. | 87.86M | 2.80% | 468,510 | 525.00K |
| 390 | CSBR | Champions Oncology, Inc. | 86.65M | -5.88% | 4,027 | 57.95M |
| 391 | ATHE | Alterity Therapeutics Limited | 85.60M | 1.66% | 7,211 | 4.43M |
| 392 | LONA | LeonaBio, Inc. | 85.29M | -3.40% | 10,172 | - |
| 393 | TELO | Telomir Pharmaceuticals, Inc. | 85.28M | - | 16,073 | - |
| 394 | RLYB | Rallybio Corporation | 84.98M | 0.25% | 15,888 | 858.00K |
| 395 | IBIO | iBio, Inc. | 84.95M | 2.40% | 826,843 | 300.00K |
| 396 | GANX | Gain Therapeutics, Inc. | 82.32M | 10.29% | 414,099 | - |
| 397 | HRTX | Heron Therapeutics, Inc. | 82.19M | 0.98% | 1,006,666 | 150.71M |
| 398 | HYFT | MindWalk Holdings Corp. | 81.20M | 3.48% | 182,424 | 20.70M |
| 399 | OKYO | OKYO Pharma Limited | 80.82M | -0.65% | 25,037 | - |
| 400 | ENTX | Entera Bio Ltd. | 80.24M | - | 250,728 | 42.00K |
| 401 | GOSS | Gossamer Bio, Inc. | 78.66M | 2.48% | 5,174,385 | 55.54M |
| 402 | ELTX | Elicio Therapeutics, Inc. | 77.81M | 2.00% | 321,656 | - |
| 403 | ANVS | Annovis Bio, Inc. | 77.21M | 5.52% | 407,412 | - |
| 404 | ACRV | Acrivon Therapeutics, Inc. | 74.05M | 2.98% | 259,511 | - |
| 405 | BYSI | BeyondSpring Inc. | 72.37M | 4.14% | 37,293 | 1.88M |
| 406 | MCRB | Seres Therapeutics, Inc. | 71.95M | 4.94% | 64,654 | 1.15M |
| 407 | CING | Cingulate Inc. | 71.39M | 6.85% | 244,387 | - |
| 408 | PLRX | Pliant Therapeutics, Inc. | 70.67M | 0.88% | 177,061 | - |
| 409 | XBIT | XBiotech Inc. | 70.43M | -0.85% | 16,006 | - |
| 410 | EXOZ | eXoZymes, Inc. | 69.87M | 2.62% | 14,971 | -700.00 |
| 411 | TCRX | TScan Therapeutics, Inc. | 67.64M | 6.83% | 842,449 | 9.14M |
| 412 | EDSA | Edesa Biotech, Inc. | 67.49M | -7.33% | 57,863 | - |
| 413 | IMA | ImageneBio, Inc. | 67.00M | -1.33% | 2,427 | 800.00K |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 66.66M | 5.04% | 410,876 | - |
| 415 | MNOV | MediciNova, Inc. | 63.94M | -1.58% | 7,146 | 596.64K |
| 416 | INKT | MiNK Therapeutics, Inc. | 58.69M | 1.20% | 8,327 | - |
| 417 | FLNA | Filana Therapeutics, Inc. | 58.45M | 0.83% | 132,748 | - |
| 418 | BOLD | Boundless Bio, Inc. | 56.49M | -1.76% | 93,922 | - |
| 419 | XLO | Xilio Therapeutics, Inc. | 56.00M | 3.43% | 44,709 | 53.48M |
| 420 | VRXA | Veraxa Biotech AG | 55.48M | -5.17% | 161,438 | - |
| 421 | ATYR | aTyr Pharma, Inc. | 54.04M | 4.48% | 817,847 | 190.00K |
| 422 | IBO | Impact BioMedical Inc. | 53.75M | 5.84% | 10,800 | 39.00K |
| 423 | LTRN | Lantern Pharma Inc. | 53.33M | 8.29% | 162,638 | - |
| 424 | DWTX | Dogwood Therapeutics, Inc. | 53.27M | -4.01% | 12,714 | - |
| 425 | CNTX | Context Therapeutics Inc. | 51.50M | -3.36% | 1,664,454 | - |
| 426 | TIL | Instil Bio, Inc. | 51.41M | 2.02% | 4,812 | - |
| 427 | IMMP | Immutep Limited | 50.88M | 5.74% | 282,823 | 5.28M |
| 428 | PDSB | PDS Biotechnology Corporation | 50.63M | 2.10% | 169,598 | - |
| 429 | VERU | Veru Inc. | 49.60M | 2.66% | 186,268 | 16.89M |
| 430 | MREO | Mereo BioPharma Group plc | 49.48M | 4.52% | 622,642 | 500.00K |
| 431 | HYPD | Hyperion DeFi, Inc. | 46.99M | 1.31% | 153,998 | 1.04M |
| 432 | ELOX | Eloxx Pharmaceuticals, Inc. | 46.92M | -3.49% | 35,403 | - |
| 433 | RADX | Radiopharm Theranostics Limited | 46.50M | 4.73% | 11,604 | 10.86M |
| 434 | MGX | Metagenomi Therapeutics, Inc. | 45.55M | -3.20% | 97,174 | 22.33M |
| 435 | APLM | Apollomics, Inc. | 45.00M | -1.49% | 7,263 | 8.84M |
| 436 | CRVO | CervoMed Inc. | 43.96M | -6.88% | 397,185 | 2.09M |
| 437 | ESLA | Estrella Immunopharma, Inc. | 43.89M | 3.79% | 15,394 | - |
| 438 | GNTA | Genenta Science S.p.A. | 43.88M | 2.76% | 220,415 | - |
| 439 | RNXT | RenovoRx, Inc. | 43.04M | 1.13% | 83,178 | 1.49M |
| 440 | INMB | INmune Bio Inc. | 42.80M | 13.38% | 915,662 | 50.00K |
| 441 | NTRB | Nutriband Inc. | 41.21M | 10.78% | 12,950 | 1.80M |
| 442 | KALA | KALA BIO, Inc. | 40.71M | -13.10% | 97,464 | - |
| 443 | ABVC | ABVC BioPharma, Inc. | 39.17M | 1.31% | 128,873 | 797.92K |
| 444 | GRCE | Grace Therapeutics, Inc. | 38.73M | - | 139,004 | - |
| 445 | ACTU | Actuate Therapeutics, Inc. | 37.80M | -5.95% | 135,178 | - |
| 446 | SNTI | Senti Biosciences Holdings, Inc. | 34.57M | 1.83% | 98,083 | 38.00K |
| 447 | ALGS | Aligos Therapeutics, Inc. | 33.73M | -2.15% | 26,970 | 4.71M |
| 448 | NNVC | NanoViricides, Inc. | 31.78M | 4.10% | 352,978 | - |
| 449 | DYAI | Dyadic International, Inc. | 31.71M | 8.65% | 79,324 | 3.81M |
| 450 | LITS | Lite Strategy, Inc. | 30.96M | 1.34% | 195,269 | - |
| 451 | GRDX | GridAI Technologies Corp. | 30.94M | 5.44% | 31,076 | - |
| 452 | LSTA | Lisata Therapeutics, Inc. | 30.87M | 0.89% | 5,619 | 170.00K |
| 453 | ATNM | Actinium Pharmaceuticals, Inc. | 30.81M | -0.82% | 60,088 | 90.00K |
| 454 | VTGN | Vistagen Therapeutics, Inc. | 30.70M | 6.57% | 1,354,507 | 1.27M |
| 455 | DARE | Daré Bioscience, Inc. | 30.60M | -2.26% | 87,793 | 1.16M |
| 456 | KYNB | Kyntra Bio, Inc. | 28.94M | -1.24% | 6,632 | 7.44M |
| 457 | SER | Serina Therapeutics, Inc. | 28.80M | 6.08% | 15,802 | 130.00K |
| 458 | PSTV | Plus Therapeutics, Inc. | 28.56M | -1.19% | 115,849 | 5.18M |
| 459 | BRNS | Barinthus Biotherapeutics plc | 27.83M | -2.67% | 22,108 | 14.97M |
| 460 | EVAX | Evaxion A/S | 27.56M | 6.92% | 10,935 | 7.53M |
| 461 | TVGN | Tevogen Bio Holdings Inc. | 27.51M | -6.14% | 47,396 | - |
| 462 | IGC | IGC Pharma, Inc. | 26.79M | 1.79% | 287,519 | 1.11M |
| 463 | BCTX | BriaCell Therapeutics Corp. | 26.67M | 2.94% | 76,575 | - |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | 24.93M | -6.91% | 1,097,094 | - |
| 465 | NEUP | Neuphoria Therapeutics Inc. | 24.46M | -0.98% | 89,904 | -13.27K |
| 466 | QNTM | Quantum BioPharma Ltd. | 24.17M | -3.95% | 64,269 | - |
| 467 | MRKR | Marker Therapeutics, Inc. | 23.68M | 7.98% | 51,415 | 3.55M |
| 468 | SKYE | Skye Bioscience, Inc. | 23.65M | -1.01% | 140,247 | - |
| 469 | PLUR | Pluri Inc. | 23.09M | 5.35% | 2,515 | 1.08M |
| 470 | PLRZ | Polyrizon Ltd. | 22.39M | 4.18% | 9,275 | - |
| 471 | VYNE | VYNE Therapeutics Inc. | 21.56M | -0.28% | 44,364 | 454.00K |
| 472 | LGVN | Longeveron Inc. | 21.55M | -3.29% | 216,157 | 1.22M |
| 473 | CLRB | Cellectar Biosciences, Inc. | 20.86M | 3.57% | 59,861 | - |
| 474 | ALLR | Allarity Therapeutics, Inc. | 20.52M | -0.77% | 21,960 | 345.00K |
| 475 | LPCN | Lipocine Inc. | 20.36M | 0.41% | 17,982 | 2.00M |
| 476 | PTN | Palatin Technologies, Inc. | 19.66M | -9.09% | 27,587 | 12.88M |
| 477 | NCEL | NewcelX Ltd. | 19.38M | -1.10% | 6,077 | - |
| 478 | AEON | AEON Biopharma, Inc. | 18.95M | -0.25% | 10,915 | - |
| 479 | MBRX | Moleculin Biotech, Inc. | 18.89M | 8.26% | 1,791,484 | - |
| 480 | CVM | CEL-SCI Corporation | 18.70M | -3.60% | 148,861 | - |
| 481 | QNCX | Quince Therapeutics, Inc. | 18.32M | -0.72% | 301,665 | - |
| 482 | CELU | Celularity Inc. | 18.23M | 1.60% | 9,142 | 26.55M |
| 483 | TVRD | Tvardi Therapeutics, Inc. | 17.87M | 27.00% | 3,808,077 | - |
| 484 | KTTA | Pasithea Therapeutics Corp. | 17.72M | -2.39% | 195,170 | - |
| 485 | ATOS | Atossa Therapeutics, Inc. | 17.39M | 7.45% | 111,644 | - |
| 486 | MLEC | Moolec Science SA | 17.06M | 7.89% | 3,690 | 7.83M |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 16.20M | 9.26% | 144,934 | 5.61M |
| 488 | CRIS | Curis, Inc. | 16.11M | 25.55% | 12,948,294 | 7.06M |
| 489 | TPST | Tempest Therapeutics, Inc. | 15.92M | -0.46% | 54,900 | - |
| 490 | GTBP | GT Biopharma, Inc. | 15.60M | 0.63% | 618,126 | - |
| 491 | PASG | Passage Bio, Inc. | 15.17M | 0.64% | 66,375 | - |
| 492 | CALC | CalciMedica, Inc. | 15.17M | 17.66% | 1,333,196 | - |
| 493 | HIND | Vyome Holdings, Inc. | 15.09M | -0.46% | 3,338 | 152.72K |
| 494 | XCUR | Exicure, Inc. | 15.04M | -1.67% | 33,913 | 500.00K |
| 495 | BIVI | BioVie Inc. | 14.67M | 0.29% | 43,562 | - |
| 496 | HOWL | Werewolf Therapeutics, Inc. | 14.42M | -8.14% | 1,360,830 | 1.14M |
| 497 | LNAI | Lunai Bioworks Inc. | 14.42M | -0.93% | 107,111 | 20.94K |
| 498 | LEXX | Lexaria Bioscience Corp. | 14.20M | 8.11% | 7,876 | 368.00K |
| 499 | BCDA | BioCardia, Inc. | 14.10M | 3.33% | 401,007 | 3.00K |
| 500 | CYCN | Cyclerion Therapeutics, Inc. | 14.00M | -2.37% | 4,172 | 1.99M |